Result of AGM

 

TIDMMEDG 
 
RNS Number : 6932S 
Medgenics Inc 
15 September 2010 
 

Medgenics, Inc. 
                         ('Medgenics' or the 'Company') 
 
                Actions Taken at Annual Meeting of Stockholders 
 
15 September 2010 
 
 
Medgenics, Inc. (AIM: MEDG, MEDU), the company that has developed a novel 
technology for the manufacture and delivery of therapeutic proteins continuously 
in patients using their own tissue, announces the actions taken at its Annual 
Meeting of Stockholders held on 13 September 2010 in New York, New York, USA. 
At a duly called meeting, at which a quorum was present in person or by proxy, 
the three proposals (as previously announced on 1 September 2010) were brought 
before the stockholders and were all passed by a majority of the votes cast. 
The first proposal related to the election of directors.  Each of the current 
directors of the Company, Dr. Eugene A. Bauer, Mr. Gary A. Brukardt, Dr. Andrew 
L. Pearlman, Dr. Stephen D. McMurray, Mr. Joel S. Kanter and Dr. Alastair 
Clemow, was duly re-elected as a director to serve until the next annual meeting 
of stockholders and until his respective successor shall have been duly elected 
and qualified. 
Pursuant to the second proposal, the stockholders ratified the selection of Kost 
Forer Gabbay & Kasierer, a member of Ernst & Young Global, to serve as the 
Company's independent registered public accounting firm for the year ended 
December 31, 2010. 
The stockholders also approved the third proposal, which was an amendment to the 
Company's 2006 Stock Incentive Plan to increase the number of shares of the 
Company's common stock $0.001 par value per share, of the Company ("Common 
Shares") available under the Plan from 48,494,572 Common Shares to 60,500,000 
Common Shares. 
More detail regarding these actions can be found in the Company's Notice of 
Annual Meeting posted on the Company's website (www.medgenics.com).  No other 
business was brought before the Annual Meeting of the Stockholders. 
 
 
 
For further information, contact: 
 
+-----------------------------------------+-----------------------------------------+ 
| Medgenics, Inc.                         | Phone: [phone]                  | 
| Dr. Andrew L. Pearlman                  |                                         | 
|                                         |                                         | 
+-----------------------------------------+-----------------------------------------+ 
| Religare Capital Markets (Nominated     | Phone: [phone]                 | 
| Adviser)                                |                                         | 
| James Pinner                            |                                         | 
| Derek Crowhurst                         |                                         | 
|                                         |                                         | 
+-----------------------------------------+-----------------------------------------+ 
| SVS Securities plc (Joint Broker)       | Phone: [phone]                 | 
| Ian Callaway                            |                                         | 
|                                         |                                         | 
+-----------------------------------------+-----------------------------------------+ 
| Nomura Code Securities PLC (Joint       | Phone: [phone]                 | 
| Broker)                                 |                                         | 
| Jon Senior                              |                                         | 
+-----------------------------------------+-----------------------------------------+ 
| De Facto Communications (Investor       | Phone : [phone]                | 
| Relations)                              | [e-mail] [e-mail] | 
| Mike Wort                               |                                         | 
| Anna Dunphy                             |                                         | 
+-----------------------------------------+-----------------------------------------+ 
| Grayling (Investor Relations - US)      | [phone]                         | 
|  Leslie Wolf-Creutzfeldt                | [e-mail]             | 
+-----------------------------------------+-----------------------------------------+ 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 RAGBCGDCRXBBGGS